» Articles » PMID: 16002959

Lung Cancer in Women: Emerging Differences in Epidemiology, Biology, and Therapy

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2005 Jul 9
PMID 16002959
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer is the major cause of cancer-related death in both men and women in the United States. Emerging evidence indicates that there are differences in the pathogenesis and possibly increased susceptibility to lung cancer in women. In addition, considerable data support small, but important differences favoring women in terms of response to therapy and long-term survival after the diagnosis of lung cancer, regardless of histology or stage. These differences in both biology and outcome will be important considerations in the design of future trials of screening and therapy for lung cancer.

Citing Articles

Histopathological Patterns of Lung Cancer in Iran: A Single-Center Study.

Salimi B, Seifi S, Khosravi A, Shiari S, Moradi R, Daneshfard B Arch Iran Med. 2024; 27(9):501-507.

PMID: 39465525 PMC: 11496601. DOI: 10.34172/aim.31133.


Sex differences in prognosis factors in patients with lung cancer: A nationwide retrospective cohort study in Korea.

Huh Y, Sohn Y, Kim H, Chun H, Kim H, Son K PLoS One. 2024; 19(5):e0300389.

PMID: 38728284 PMC: 11086892. DOI: 10.1371/journal.pone.0300389.


Demographic and clinical characteristics of primary lung cancer patients in Kerala: Analysis of data from six teaching centers.

Jose N, Soman B, Thulaseedharan J, Varghese B, Thomas S, Tom J J Family Med Prim Care. 2023; 12(10):2501-2506.

PMID: 38074238 PMC: 10706524. DOI: 10.4103/jfmpc.jfmpc_2176_22.


Gender Differences in Oxidative Stress in Relation to Cancer Susceptibility and Survival.

Allegra A, Caserta S, Genovese S, Pioggia G, Gangemi S Antioxidants (Basel). 2023; 12(6).

PMID: 37371985 PMC: 10295142. DOI: 10.3390/antiox12061255.


Prediction of the Presence of Targetable Molecular Alteration(s) with Clinico-Metabolic F-FDG PET Radiomics in Non-Asian Lung Adenocarcinoma Patients.

Aide N, Weyts K, Lasnon C Diagnostics (Basel). 2022; 12(10).

PMID: 36292136 PMC: 9601118. DOI: 10.3390/diagnostics12102448.